This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pratt, C. B. Search for Related Content PubMed PubMed Citation Articles by Pratt, C. B.

Pediatric Clinical Trials

Department of Hematology/Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA

Correspondence: Charles B. Pratt, M.D., St. Jude Children’s Research Hospital, Department of Hematology/Oncology, 332 North Lauderdale, Memphis, TN 38105, USA. Telephone: 901-495-3442; Fax: 901-521-9005.

Clinical trials specifically tailored to the unique tumors and leukemias of children have resulted in increased survival rates approaching or exceeding 70% for most diseases. These studies have been carried out by investigators at large, independent institutions or through the auspices of the Children’s Cancer Group or Pediatric Oncology Group. The National Cancer Institute has also supported pediatric disease—focused efforts for rhabdomyosarcoma, Wilms tumor, Ewing’s sarcoma, osteosarcomas and other diseases. The present-day training of pediatric hematology/oncology fellows assures continuing contributions to the biology of childhood malignant lesions through applications of translational research.

Key Words. Childhood tumors • Leukemia • Chemotherapy • Surgery • Radiation therapy

This article has been cited by other articles:

				C. M. Ulrich, C. Grady, and D. Wendler Palliative Care: A Supportive Adjunct to Pediatric Phase I Clinical Trials for Anticancer Agents? Pediatrics, September 1, 2004; 114(3): 852 - 855. [Full Text] [PDF]